Get started
Author

Christian Uprimny

Observed names: C Uprimny, C. Uprimny, Uprimny, Christian
Institution: Klinikum Klagenfurt
Observed institutions: Innsbruck Medical University, Universität Innsbruck, University Hospital Heidelberg, Klinikum Klagenfurt, Tirol Kliniken, University Hospital Innsbruck
ORCID: 0000-0001-5588-3363
Observed ORCID: 0000-0001-5588-3363
OpenAlex ID: A5078589645
68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT
2007 · M. Gabriel, C. Decristoforo, et al. · Journal of Nuclear Medicine · 1,007
PDF
68Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour
2017 · Christian Uprimny, Alexander Stephan Kroiss, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 355
68Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?
2015 · Francesco Ceci, Christian Uprimny, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 267
Bone Metastases in Patients with Neuroendocrine Tumor: 68Ga-DOTA-Tyr3-Octreotide PET in Comparison to CT and Bone Scintigraphy
2009 · Daniel Putzer, Michael Gabriel, et al. · Journal of Nuclear Medicine · 217
PDF
68Ga-DOTA-Tyr3-Octreotide PET for Assessing Response to Somatostatin-Receptor–Mediated Radionuclide Therapy
2009 · Michael Gabriel, Andreas Oberauer, et al. · Journal of Nuclear Medicine · 193
PDF
Third-line treatment and 177Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review
2017 · Finn Edler von Eyben, Giandomenico Roviello, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 188
PDF
Current status of theranostics in prostate cancer
2017 · Irene Virgolini, Clemens Decristoforo, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 161
PDF
Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine
2011 · Alexander Kroiss, Daniel Putzer, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 134
The 68Ga/177Lu theragnostic concept in PSMA targeting of castration-resistant prostate cancer: correlation of SUVmax values and absorbed dose estimates
2017 · Lorenza Scarpa, Sabine Buxbaum, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 119
PDF
Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine: a clarification
2012 · Alexander Kroiss, Daniel Putzer, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 117
PDF
Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesions
2017 · Stefano Fanti, Silvia Minozzi, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 114
68Ga-DOTA-TOC uptake in neuroendocrine tumour and healthy tissue: differentiation of physiological uptake and pathological processes in PET/CT
2013 · A. Kroiss, D. Putzer, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 108
Direct comparison of 68Ga-DOTA-TOC and 18F-FDG PET/CT in the follow-up of patients with neuroendocrine tumour treated with the first full peptide receptor radionuclide therapy cycle
2016 · Bernhard Nilica, Dietmar Waitz, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 92
PDF
A retrospective comparison between 68Ga-DOTA-TOC PET/CT and 18F-DOPA PET/CT in patients with extra-adrenal paraganglioma
2013 · Alexander Kroiss, Daniel Putzer, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 87
Early dynamic imaging in 68Ga- PSMA-11 PET/CT allows discrimination of urinary bladder activity and prostate cancer lesions
2016 · Christian Uprimny, Alexander Stephan Kroiss, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 83
Organ-sparing surgery of penile cancer: higher rate of local recurrence yet no impact on overall survival
2019 · Andrea Katharina Lindner, Gert Schachtner, et al. · World Journal of Urology · 74
PDF
Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy
2021 · Matt Lechner, Volker H. Schartinger, et al. · Nature Communications · 67
MITIGATE-NeoBOMB1, a Phase I/IIa Study to Evaluate Safety, Pharmacokinetics, and Preliminary Imaging of 68Ga-NeoBOMB1, a Gastrin-Releasing Peptide Receptor Antagonist, in GIST Patients
2020 · Leonhard Gruber, Luis David Jiménez-Franco, et al. · Journal of Nuclear Medicine · 64
PDF
The 68Ga/177Lu-theragnostic concept in PSMA-targeting of metastatic castration–resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up
2019 · Johanna Maffey-Steffan, Lorenza Scarpa, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 61
PDF
68Ga-DOTATOC PET/CT provides accurate tumour extent in patients with extraadrenal paraganglioma compared to 123I-MIBG SPECT/CT
2014 · Alexander Kroiss, Barry Lynn Shulkin, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 60
Early PET imaging with [68]Ga-PSMA-11 increases the detection rate of local recurrence in prostate cancer patients with biochemical recurrence
2017 · Christian Uprimny, Alexander Stephan Kroiss, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 56
Comparison of [68Ga]Ga-PSMA-11 PET/CT with [18F]NaF PET/CT in the evaluation of bone metastases in metastatic prostate cancer patients prior to radionuclide therapy
2018 · Christian Uprimny, Anna Svirydenka, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 52
Somatostatin receptor PET in neuroendocrine tumours: 68Ga-DOTA0,Tyr3-octreotide versus 68Ga-DOTA0-lanreotide
2012 · Daniel Putzer, Alexander Kroiss, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 51
Pelvic Lymph Node Staging by Combined 18F-FDG-PET/CT Imaging in Bladder Cancer Prior to Radical Cystectomy
2016 · Renate Pichler, Tobias De Zordo, et al. · Clinical Genitourinary Cancer · 49
Current knowledge on the sensitivity of the 68Ga-somatostatin receptor positron emission tomography and the SUVmax reference range for management of pancreatic neuroendocrine tumours
2016 · Irene Virgolini, Michael Gabriel, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 40
PDF
Works count: 104
Citation count: 4,465
H-index: 28
I10-index: 54
Year
Topic
Type